By contrast, RSF-1 knockdown by siRNA treatment or functional competition with deletion mutants reduced cell growth, increased drug sensitivity and triggered cell death in cancer cells with RSF-1-overexpression [19, 20]. The gene discussed is RSF1; the disease is cancer.